MegatrendsMegatrends: not the usual suspects, but who actually profits.View megatrends →

Metrics as of 10/15/2026, 05:58 PM (Berlin time), refresh in progress.

CareCloud Stock

CareCloud, Inc.

CCLDNASDAQMarkt
US$1.95
+10.2% today

Company data

Sector
Healthcare
Industry
Medical - Healthcare Information Services
Country
United States
CEO
Stephen A. Snyder
Employees
3,650
Market cap
$83 M
IPO
23/07/2014

CareCloud, Inc. operates as a specialized healthcare technology firm, delivering a comprehensive portfolio of cloud-powered solutions and related professional services. Its primary clientele consists of medical providers and hospitals throughout the United States. The company strategically organizes its activities…

CareCloud stock: price history

15/10/25-38.7 %15/10/26

1D

+10.2%

1W

+0.5%

1M

-4.9%

6M

-36.1%

YTD

-33.2%

1Y

-38.7%

2Y

-22.0%

5Y

-74.0%

10Y

+121.6%

Next earnings date

Next earnings date

05/11/2026 (in 19 days)

Volatility around earnings

~48% stronger price swings than usual

Ask the agents about CareCloud

Analyst assessment of CareCloud

PRICE TARGET LOW

US$3.00

CONSENSUS

US$3.13

MEDIAN

US$3.13

PRICE TARGET HIGH

US$3.25

0

STRONG BUY

6

BUY

2

HOLD

0

SELL

0

STRONG SELL

8

TOTAL · Buy

As of: 12/03/2026

ANALYST FIRMRATINGACTIONDATE
Roth CapitalNeutralmaintain12/03/2026
Roth MKMNeutralmaintain14/03/2025 (older than 12 months)
BenchmarkBuymaintain15/11/2024 (older than 12 months)
BenchmarkBuymaintain16/05/2024 (older than 12 months)
BenchmarkBuymaintain25/03/2024 (older than 12 months)
Maxim GroupHold → Buyupgrade22/03/2024 (older than 12 months)
BenchmarkBuymaintain16/11/2023 (older than 12 months)
Roth MKMBuy → Neutraldowngrade04/08/2023 (older than 12 months)

CareCloud stock metrics

P/E

27.94

P/B

4.76

EV/EBITDA

4.35

RETURN ON EQUITY

6.4%

NET MARGIN

3.5%

DEBT/EQUITY

3.1

DIVIDEND YIELD

0.0%

AS OF

30/06/2026

Free float & liquidity

FREE FLOAT

60.0%

FLOAT SHARES

25,497,037

AVG. DAILY VOLUME (30D)

243,357

Insider transactions (SEC)

ROLETRANSACTIONSHARESPRICEPLAN TYPEDATE

BUSQUET ANNE

DirectorOption exercise7,500–Spontaneous10/08/2026

KORN BILL

DirectorOption exercise7,500–Spontaneous10/08/2026

Sharnak Lawrence Steven

DirectorOption exercise7,500–Spontaneous10/08/2026

MUNTER CAMERON

DirectorOption exercise7,500–Spontaneous10/08/2026

MUNTER CAMERON

DirectorOption exercise6,250–Spontaneous31/07/2026
Page 1 / 3

Institutional holders

FUND / INSTITUTIONSHARESCHANGEAS OF
VANGUARD CAPITAL MANAGEMENT LLC1,680,820+207,11930/06/2026
Hillsdale Investment Management Inc.923,408+118,90030/06/2026
TWO SIGMA INVESTMENTS, LP579,826+190,20030/06/2026
DIMENSIONAL FUND ADVISORS LP575,970+198,40330/06/2026
AMERICAN CENTURY COMPANIES INC509,693-229,87730/06/2026
Page 1 / 3

Comparable stocks

Frequently asked questions about CareCloud stock

What does CareCloud do?

CareCloud, Inc. is a company in the Healthcare sector, Medical - Healthcare Information Services industry, headquartered in United States.

The CEO is Stephen A. Snyder, the company employs around 3,650 people.

The IPO was on 23/07/2014; the stock trades on NASDAQ under the ticker CCLD.

What do analysts say about CareCloud stock?

8 analysts rate the stock, the consensus is Buy (as of 12/03/2026).

The average price target is US$3.13, ranging from US$3.00 to US$3.25, with a median of US$3.13.

This is an external assessment, not a statement by Market Jury.

When does CareCloud report next?

The next earnings date is 05/11/2026.

Around past earnings, price swings were roughly 48% stronger than usual.

Does CareCloud pay a dividend?

No, CareCloud currently does not pay a dividend.

Which stocks are comparable to CareCloud?

Comparable stocks include Hinge Health, HealthEquity, Heartflow, Omada Health, Teladoc Health, Evolent Health, SOPHiA GENETICS and Optima Health.

How can I get CareCloud stock analyzed?

Clicking "Analyze stock" lets five strategies assess CareCloud against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.

Not investment advice. Past performance is not an indicator of future results.